Pazopanib improved PFS in advanced, metastatic renal cell cancer | HemOncToday
Links shared publicly online about this topic.
- 1,423total visits
Pazopanib improved PFS in advanced, metastatic renal cell cancer | HemOncToday
Pazopanib demonstrated significant improvement in PFS and tumor response rates in patients with treatment-naïve renal cell cancer when c
View full resource at hemonctoday.com
Tags: Cancer, Kidney Cancer, Renal Cell Carcinoma, Kidney Health, Urinary System, Drug, FDA
Most Recently Shared on January 28, 2010 at 1:09 pm By:
#JCO Pazopanib improved PFS in advanced, metastatic renal cell cancer. Data used for FDA drug approval published. http://ow.ly/11kxv
Advertisement
